Valuation: Fresenius

Market Cap 26.03B 30.41B 24.33B 22.3B 41.92B 2,909B 42.74B 288B 112B 1,461B 114B 112B 4,835B P/E 2026 *
14.1x
P/E 2027 * 12.2x
Enterprise Value 36.4B 42.52B 34.02B 31.19B 58.61B 4,068B 59.77B 403B 157B 2,042B 160B 156B 6,760B EV / Sales 2026 *
1.53x
EV / Sales 2027 * 1.43x
Free-Float
73%
Yield 2026 *
2.53%
Yield 2027 * 2.72%
Manager TitleAgeSince
Chief Executive Officer 57 01/10/2022
Director of Finance/CFO 46 01/09/2022
Compliance Officer 50 -
Director TitleAgeSince
Director/Board Member 71 20/05/2015
Director/Board Member 65 13/05/2016
Director/Board Member 52 01/01/2016
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 30.63B
0.00%-1.13%+31.96%+40.17% 120B
-0.19%-2.01%+0.89%+51.01% 88.13B
-0.19%+1.48%+31.98%+80.75% 26.68B
-0.25%+2.41%-5.63%-8.54% 22.22B
+1.52%+2.18%+53.12%+285.68% 21.62B
+0.30%-2.29%-9.61%+12.58% 14.18B
-0.10%-0.29%-4.93%-8.26% 12.65B
-1.15%-3.45%+28.21%+72.55% 11.3B
-3.53%+10.38%+131.45%+2,074.24% 10.2B
Average -0.36%+1.50%+28.60%+288.91% 36.31B
Weighted average by Cap. -0.11%-0.15%+22.17%+120.90%

Financials

2026 *2027 *
Net sales 23.76B 27.76B 22.21B 20.36B 38.26B 2,656B 39.02B 263B 102B 1,333B 104B 102B 4,413B 24.98B 29.18B 23.35B 21.4B 40.22B 2,792B 41.02B 277B 108B 1,402B 110B 107B 4,639B
Net income 1.89B 2.21B 1.76B 1.62B 3.04B 211B 3.1B 20.9B 8.14B 106B 8.28B 8.1B 351B 2.16B 2.52B 2.01B 1.85B 3.47B 241B 3.54B 23.87B 9.3B 121B 9.45B 9.24B 400B
Net Debt 10.37B 12.11B 9.69B 8.88B 16.7B 1,159B 17.03B 115B 44.71B 582B 45.46B 44.46B 1,926B 9.57B 11.18B 8.95B 8.2B 15.42B 1,070B 15.72B 106B 41.28B 537B 41.97B 41.05B 1,778B
Logo Fresenius
Fresenius SE & Co. KGaA is a Germany-based healthcare group focused on products and services for the treatment of critically and chronically ill patients. The Company operates through its core businesses, Fresenius Kabi and Fresenius Helios. Fresenius Kabi develops and supplies biopharmaceuticals, clinical nutrition products, medical technologies, intravenously administered generic drugs, and infusion therapies. Fresenius Helios is Europe’s private healthcare provider, operating hospitals, outpatient centers, and other healthcare facilities in Germany, Spain, and Latin America. Fresenius also holds an investment in Fresenius Medical Care, a provider of dialysis products and services for patients with chronic kidney disease.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
46.22EUR
Average target price
55.86EUR
Spread / Average Target
+20.87%

Quarterly revenue - Rate of surprise